Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients

Table 3 Overall mortality in the subsample of patients of median age (51.7 years) or below

Variable	Univariable analyses			Multivariable analysis
Variable	HR	95 % CI	p	HR	95 % CI	p
^aLow MAp44	2.91	1.61–5.27	0.001	2.57	1.42–4.66	0.002
Recipient age, per year	1.05	1.01–1.09	0.012	1.04	1.00–1.08	0.05
Donor age, per year	1.02	0.99–1.04	0.11	1.02	1.00–1.04	0.09
^aDiabetic nephropathy	2.16	1.14–4.11	0.019	1.93	0.93–3.98	0.08
^aCoronary heart disease	3.56	1.61–6.57	0.001	1.91	0.88–4.18	0.10
^aHypertensiv nephrosclerosis	0.73	0.23–2.34	0.59
^aCMV infection	2.42	0.33–17.73	0.38
^aLiving donor	0.90	0.51–1.61	0.90
^aRecipient gender, female	1.45	0.81–2.60	0.21
^aPreemptive transplantation	1.08	0.52–2.23	0.84
^aInduction, basiliximab	1.04	0.57–1.87	0.91

ISSN: 1471-2369